Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment. (Q54356882)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment. (English)

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

1 reference

based on heuristic

inferred from title

7

object named as

Kwhanmien Kim

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

6

object named as

Sanghoon Jheon

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

8

object named as

Choon Taek Lee

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

author name string

Ping-Li Sun

1

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Ji Eun Kim

2

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Seol Bong Yoo

3

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Hyojin Kim

4

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Yan Jin

5

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Jin-Haeng Chung

9

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

publication date

26 April 2014

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Annals of Surgical Oncology

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

21 Suppl 4

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

S610-8

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

https://scigraph.springernature.com/pub.10.1245/s10434-014-3715-5

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

The hippo signaling pathway in development and cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Elucidation of a universal size-control mechanism in Drosophila and mammals

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

From cell structure to transcription: Hippo forges a new path

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Expression of Yes-associated protein in common solid tumors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase In

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

The new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issues

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

EGFR testing in lung cancer is ready for prime time

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Mechanisms of acquired resistance to targeted cancer therapies.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Tissue microarrays in clinical oncology

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3715-5

21 January 2018

Identifiers

10.1245/S10434-014-3715-5

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 May 2018

http://europepmc.org/abstract/MED/24770679

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54356882&oldid=1690427884"